At $CLAV (+1,12%) an extraordinary general meeting was held on December 17 to approve a share issue of SEK 167 million. The dilution amounts to approx. 16.67%. Price: SEK 2.70.
Together with a new short-term loan from Swedbank in the amount of SEK 100 million, the company pays $CLAV (+1,12%) repays interest (SEK 92 million) / loan (SEK 83 million) to the EIB ahead of schedule and also repurchases 15,360,591 warrants at a price of SEK 2.70.
The loan from the EIB was in € and the loan from Swedbank is in SEK in order to minimize the currency risk.
This debt rescheduling reduces the annual interest payments by SEK 2 million.
$CLAV (+1,12%) Swedbank also expects this to make the company more attractive to long-term investors and give it greater strategic flexibility to grow more strongly in key customer segments.
The share price has fallen by around 20% since the Q3 earnings at the beginning of November. Even though Q3 2025 was quite positive in isolation with +15.3% net sales and EBIT of SEK 2.1 million, the growth and EBIT targets for 2025 had to be reduced due to lower incoming orders (-8.8%). Some major orders appear to have been postponed from Q4 /2025 to Q1 /2026.
How do you see $CLAV (+1,12%) in 2026? I am invested with a small amount and am currently undecided about how to proceed. How do you see the sales/order development and potential?
